In pro-proliferative cytokine environment—and we assume that particular situation at the onset of myeloproliferative diseases—SOCS1 suppresses the predominantly pro-proliferative cytokines and thus prolongs or even prevents BCR-ABL mediated transformation. Here, ABL1 is linked to myeloproliferative disorder.